Overview
Elizabeth Loggers is an Oncologist in Seattle, Washington. Dr. Loggers is highly rated in 28 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Liposarcoma, Angiosarcoma, and Liver Embolization.
Her clinical research consists of co-authoring 99 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
The Association Of University Physicians
Ajay Gopal is an Oncologist in Seattle, Washington. Dr. Gopal is highly rated in 23 conditions, according to our data. His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and B-Cell Lymphoma. Dr. Gopal is currently accepting new patients.
The Association Of University Physicians
Petros Grivas is an Oncologist in Seattle, Washington. Dr. Grivas is highly rated in 9 conditions, according to our data. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Endoscopy. Dr. Grivas is currently accepting new patients.
The Association Of University Physicians
Bart Scott is an Oncologist in Seattle, Washington. Dr. Scott is highly rated in 13 conditions, according to our data. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Leukemia, and Bone Marrow Aspiration. Dr. Scott is currently accepting new patients.
Frequently Asked Questions about Dr. Elizabeth Loggers
How do I make an appointment with Dr. Elizabeth Loggers?
You can book an appointment with Dr. Elizabeth Loggers by calling their office at 855-557-0555. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Elizabeth Loggers a top-rated expert for Adult Soft Tissue Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth Loggers is classified as an Elite expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Elizabeth Loggers specialize in?
While Dr. Elizabeth Loggers is a Oncology, they have specific expertise in Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, and Liposarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Elizabeth Loggers participate in research or clinical trials?
Yes. Dr. Elizabeth Loggers has published 99 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Dr. Elizabeth Loggers's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Elizabeth Loggers accept my insurance?
Dr. Elizabeth Loggers accepts most major insurance plans, including Cambia Health Solutions and Cigna. We recommend calling the office directly at 855-557-0555 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult Soft Tissue SarcomaDr. Loggers isElite. Learn about Adult Soft Tissue Sarcoma.
- Distinguished
- Alveolar Soft Part SarcomaDr. Loggers isDistinguished. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Loggers isDistinguished. Learn about Angiosarcoma.
- Bone TumorDr. Loggers isDistinguished. Learn about Bone Tumor.
- Desmoid TumorDr. Loggers isDistinguished. Learn about Desmoid Tumor.
- Epithelioid SarcomaDr. Loggers isDistinguished. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Loggers isDistinguished. Learn about Fibrosarcoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Loggers isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Angiosarcoma of the ScalpDr. Loggers isAdvanced. Learn about Angiosarcoma of the Scalp.
- ChondrosarcomaDr. Loggers isAdvanced. Learn about Chondrosarcoma.
- Desmoplastic Small Round Cell TumorDr. Loggers isAdvanced. Learn about Desmoplastic Small Round Cell Tumor.
- Ewing SarcomaDr. Loggers isAdvanced. Learn about Ewing Sarcoma.
- Experienced
- Breast CancerDr. Loggers isExperienced. Learn about Breast Cancer.
- ChordomaDr. Loggers isExperienced. Learn about Chordoma.
- Colorectal CancerDr. Loggers isExperienced. Learn about Colorectal Cancer.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Loggers isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Endometrial CancerDr. Loggers isExperienced. Learn about Endometrial Cancer.
- Fibrolamellar CarcinomaDr. Loggers isExperienced. Learn about Fibrolamellar Carcinoma.